“…While there has been considerable effort in glycoengineering popular expression hosts such as Nicotiana benthamiana , N. tabacum , tobacco BY2 cells and the moss Physcomitrella patens towards humanized- and customized N-glycosylation ( Bakker et al, 2001 ; Koprivova et al, 2004 ; Strasser et al, 2008 ; Kallolimath et al, 2016 ; Limkul et al, 2016 ; Mercx et al, 2017 ; Jansing et al, 2019 ; Bohlender et al, 2020 ; Herman et al, 2021 ; Göritzer et al, 2022 ; Kogelmann et al, 2023 ) limited attention was cast towards modulating the plant endogenous O-glycosylation pathway ( Castilho et al, 2012 ; Yang et al, 2012 ; Parsons et al, 2013 ; Dicker et al, 2016 ; Ramírez-Alanis et al, 2018 ; Mócsai et al, 2021 ; Uetz et al, 2022 ). Plant-endogenous HyP and further modifications with pentoses (arabinoses) were found in several recombinantly produced proteins such as IgA1, MUC1, EPO-Fc, and Ara h 2 ( Karnoup et al, 2005 ; Weise et al, 2007 ; Pinkhasov et al, 2011 ; Castilho et al, 2012 ; Yang et al, 2012 ; Üzülmez et al, 2021 ). The impact of these plant-specific HyP residues and attached pentoses on the function and potency of therapeutic proteins is currently unknown.…”